Legal Representation
Attorney
Cecilia R. Dickson
USPTO Deadlines
Next Renewal Deadline
960 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-22)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 26, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Feb 26, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Feb 26, 2025 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Feb 26, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 26, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 16, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Jul 27, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Jul 27, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED |
| May 22, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Feb 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 13, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Dec 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 17, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Nov 17, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Nov 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 2, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 1, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 14, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 14, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 14, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 9, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 9, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Apr 9, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 9, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Apr 9, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Apr 9, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 7, 2020 | RFNT | P | REFUSAL PROCESSED BY IB |
| Nov 16, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Nov 16, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Oct 27, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Oct 26, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 23, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Oct 22, 2020 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Oct 19, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 19, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 15, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemical test kits for analysis of proteins; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemicals for use in scientific analysis, scientific research and for industrial purposes
Class 005
Diagnostic chemicals for medical or veterinary purposes; clinical diagnostic reagents for medical or veterinary use; medical diagnostic reagents and test strips for testing of body fluids; diagnostic preparations, substances, test reagents and reagents for medical and veterinary purposes and for medical and veterinary use; medical diagnostic reagents and samples in the nature of assays for testing body fluids
Class 042
Diagnostic development, namely, development of diagnostic apparatus and preparations; biotechnological services, namely, biotechnological research, development of new technology for others in the field of biotechnology; immunoassay-related services, namely, development of chemical reagents and biochemical assays; immunoassay-related services, namely, validation, in the nature of evaluating and quality testing biochemical assays; immunoassay-related services, namely, production in the nature of product development in the field of biochemical assays; immunoassay-related services, namely, analyzing in the nature of chemical analysis of biochemical assays
Additional Information
Design Mark
The mark consists of two stacked red parallelograms next to the red stylized wording "MERCODIA".
Color Claim
The color(s) red is/are claimed as a feature of the mark.
Classification
International Classes
001
005
042